Home
Scholarly Works
Long-term safety for patients with...
Journal article

Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma

Authors

Jaeger U; Tam CS; Borchmann P; McGuirk JP; Johansen M; Waller EK; Jaglowski S; Andreadis C; Foley SR; Westin JR

Journal

Blood Advances, Vol. 6, No. 16, pp. 4816–4820

Publisher

American Society of Hematology

Publication Date

August 23, 2022

DOI

10.1182/bloodadvances.2021006193

ISSN

2473-9529

Contact the Experts team